Genexineincis A Clinical Stage Biotechnology Company Based In Seoulsouth Koreafounded In 1999The Company Aims To Become A Leading Global Biopharmaceutical Entity By 2030With Over Two Decades Of Experiencegenexine Specializes In The Development And Commercialization Of Immunotherapeutics And Next Generation Biologics The Company Utilizes A Hybrid Fc Technology Platform To Create Long Acting Protein Therapeuticsessential For Treating Various Diseasesgenexine Also Employs A Dna Vaccine Platform To Stimulate Immune Responses Against Viral Infections And Cancerits Diverse Product Pipeline Includes Candidates In Various Clinical Trial Phasestargeting Conditions Such As Growth Hormone Deficiencyanemianeutropeniasolid Tumorsautoimmune Diseasesdiabetesand Cervical Cancer Genexine Collaborates With Other Pharmaceutical Companies For Research And Developmentextending Its Reach In Both South Korea And The United Statesthe Company Is Dedicated To Addressing Unmet Medical Needsfocusing On Orphan Diseasescancersand Immune Disorders Through Innovative Therapies
No conferences found for this company.
| Company Name | Genexine Inc |
| Country |
South Korea
|
| Address | N/A |
| Telephone | N/A |
| N/A |
